AAAAAA

   
Results: 1-10 |
Results: 10
Tribute to Dr. Maureen Andrew
Authors: Coppes, MJ Blanchette, VS
Citation: Mj. Coppes et Vs. Blanchette, Tribute to Dr. Maureen Andrew, J PED H ONC, 23(8), 2001, pp. 476-477
Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: Decision analysis
Authors: Klaassen, RJ Doyle, JJ Krahn, MD Blanchette, VS Naglie, G
Citation: Rj. Klaassen et al., Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: Decision analysis, J PED H ONC, 23(8), 2001, pp. 511-518
The management of alloimmune neonatal thrombocytopenia
Authors: Blanchette, VS Johnson, J Rand, M
Citation: Vs. Blanchette et al., The management of alloimmune neonatal thrombocytopenia, BEST P R C, 13(3), 2000, pp. 365-390
von Willebrand Disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 (R) and a von Willebrand factor/collagen-binding assay
Authors: Dean, JA Blanchette, VS Carcao, MD Stain, AM Sparling, CR Siekmann, J Turecek, PL Lillicrap, D Rand, ML
Citation: Ja. Dean et al., von Willebrand Disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 (R) and a von Willebrand factor/collagen-binding assay, THROMB HAEM, 84(3), 2000, pp. 401-409
Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens
Authors: Bang, KWA Speck, ER Blanchette, VS Freedman, J Semple, JW
Citation: Kwa. Bang et al., Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens, BLOOD, 95(5), 2000, pp. 1735-1742
The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada
Authors: Chang, H Sher, GD Blanchette, VS Teitel, JM
Citation: H. Chang et al., The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada, HAEMOPHILIA, 5(4), 1999, pp. 247-252
Essential thrombocythemia in children
Authors: Dror, Y Zipursky, A Blanchette, VS
Citation: Y. Dror et al., Essential thrombocythemia in children, J PED H ONC, 21(5), 1999, pp. 356-363
Essential thrombocythaemia in children
Authors: Dror, Y Blanchette, VS
Citation: Y. Dror et Vs. Blanchette, Essential thrombocythaemia in children, BR J HAEM, 107(4), 1999, pp. 691-698
Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity
Authors: Semple, JW Speck, ER Cosgrave, D Lazarus, AH Blanchette, VS Freedman, J
Citation: Jw. Semple et al., Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity, BLOOD, 93(2), 1999, pp. 713-720
Use of the PFA-100 (R) in the assessment of primary, platelet-related hemostasis in a pediatric setting
Authors: Rand, ML Carcao, MD Blanchette, VS
Citation: Ml. Rand et al., Use of the PFA-100 (R) in the assessment of primary, platelet-related hemostasis in a pediatric setting, SEM THROMB, 24(6), 1998, pp. 523-529
Risultati: 1-10 |